Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R. Janes, Lomon So, Jing Chen et al.|Nature Medicine|2010Cited by 338
Statins enhance efficacy of venetoclax in blood cancersJ. Scott Lee, Andrew W. Roberts, Dennis Juarez et al.|Science Translational Medicine|2018Cited by 86